Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report

Autoimmune diseases (ADs) are closely related to cancers; 30% of dermatomyositis (DM) cases are associated with malignancy. In lung cancer patients accompanied by DM, the most frequent cancer type is small cell lung cancer (SCLC). Anti‐transcriptional intermediary factor 1 γ (anti‐TIF1γ) antibody is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoonjoo, Park, Dongil, Choi, Song‐Yi, Chung, Chaeuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527166/
https://www.ncbi.nlm.nih.gov/pubmed/35982637
http://dx.doi.org/10.1111/1759-7714.14609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527166/
https://www.ncbi.nlm.nih.gov/pubmed/35982637
http://dx.doi.org/10.1111/1759-7714.14609

Ejemplares similares